SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-162650
Filing Date
2023-06-07
Accepted
2023-06-07 17:09:05
Documents
14
Period of Report
2023-06-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d446142d8k.htm   iXBRL 8-K 29072
2 EX-1.1 d446142dex11.htm EX-1.1 206186
  Complete submission text file 0001193125-23-162650.txt   447391

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btmd-20230605.xsd EX-101.SCH 4061
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE btmd-20230605_def.xml EX-101.DEF 13598
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20230605_lab.xml EX-101.LAB 22501
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20230605_pre.xml EX-101.PRE 14566
8 EXTRACTED XBRL INSTANCE DOCUMENT d446142d8k_htm.xml XML 5345
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 23999784
SIC: 2833 Medicinal Chemicals & Botanical Products